Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 3
1967 2
1968 1
1969 2
1970 1
1971 1
1972 1
1973 5
1974 7
1975 1
1977 1
1978 2
1979 4
1980 3
1981 9
1982 7
1983 10
1984 12
1985 7
1986 8
1987 8
1988 8
1989 12
1990 11
1991 6
1992 8
1993 13
1994 20
1995 11
1996 21
1997 11
1998 19
1999 12
2000 20
2001 24
2002 18
2003 17
2004 22
2005 30
2006 34
2007 45
2008 48
2009 50
2010 42
2011 47
2012 56
2013 73
2014 97
2015 102
2016 95
2017 110
2018 113
2019 113
2020 125
2021 153
2022 167
2023 169
2024 163
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,991 results

Results by year

Filters applied: . Clear all
Page 1
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
Hofland J, Falconi M, Christ E, Castaño JP, Faggiano A, Lamarca A, Perren A, Petrucci S, Prasad V, Ruszniewski P, Thirlwell C, Vullierme MP, Welin S, Bartsch DK. Hofland J, et al. Among authors: prasad v. J Neuroendocrinol. 2023 Aug;35(8):e13318. doi: 10.1111/jne.13318. Epub 2023 Aug 14. J Neuroendocrinol. 2023. PMID: 37578384 Free article.
The Reply.
Olivier T, Gill J, Prasad V. Olivier T, et al. Among authors: prasad v. Am J Med. 2023 Mar;136(3):e48. doi: 10.1016/j.amjmed.2022.10.012. Am J Med. 2023. PMID: 36796954 No abstract available.
Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy.
Duncan CN, Bledsoe JR, Grzywacz B, Beckman A, Bonner M, Eichler FS, Kühl JS, Harris MH, Slauson S, Colvin RA, Prasad VK, Downey GF, Pierciey FJ, Kinney MA, Foos M, Lodaya A, Floro N, Parsons G, Dietz AC, Gupta AO, Orchard PJ, Thakar HL, Williams DA. Duncan CN, et al. Among authors: prasad vk. N Engl J Med. 2024 Oct 10;391(14):1287-1301. doi: 10.1056/NEJMoa2405541. N Engl J Med. 2024. PMID: 39383458 Clinical Trial.
CME: Is it Meeting the Mark?
Ranganathan S, Prasad V. Ranganathan S, et al. Among authors: prasad v. Am J Med. 2023 Jul;136(7):618-619. doi: 10.1016/j.amjmed.2023.02.010. Epub 2023 Mar 9. Am J Med. 2023. PMID: 36898599 No abstract available.
Editorial: Response assessment of radioligand therapies.
Lopci E, Prasad V. Lopci E, et al. Among authors: prasad v. Front Oncol. 2022 Jul 27;12:904337. doi: 10.3389/fonc.2022.904337. eCollection 2022. Front Oncol. 2022. PMID: 35965585 Free PMC article. No abstract available.
Pembrolizumab for all.
Kim MS, Prasad V. Kim MS, et al. Among authors: prasad v. J Cancer Res Clin Oncol. 2023 Mar;149(3):1357-1360. doi: 10.1007/s00432-022-04412-4. Epub 2022 Oct 22. J Cancer Res Clin Oncol. 2023. PMID: 36271954 Free PMC article.
Enhanced SARS-CoV-2 entry via UPR-dependent AMPK-related kinase NUAK2.
Prasad V, Cerikan B, Stahl Y, Kopp K, Magg V, Acosta-Rivero N, Kim H, Klein K, Funaya C, Haselmann U, Cortese M, Heigwer F, Bageritz J, Bitto D, Jargalsaikhan S, Neufeldt C, Pahmeier F, Boutros M, Yamauchi Y, Ruggieri A, Bartenschlager R. Prasad V, et al. Mol Cell. 2023 Jul 20;83(14):2559-2577.e8. doi: 10.1016/j.molcel.2023.06.020. Epub 2023 Jul 7. Mol Cell. 2023. PMID: 37421942 Free article.
High US drug prices have global implications.
Jenei K, Prasad V, Lythgoe MP. Jenei K, et al. Among authors: prasad v. BMJ. 2022 Mar 22;376:o693. doi: 10.1136/bmj.o693. BMJ. 2022. PMID: 35318198 No abstract available.
1,991 results